![Justin Fairchild](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Justin Fairchild
Corporate Officer/Principal presso PORTAGE BIOTECH INC.
Profilo
Justin Fairchild is currently working as Vice President-Development at Portage Biotech, Inc. and Vice President-Clinical Development at The Parker Institute For Cancer Immunotherapy.
He completed his undergraduate degree from Colgate University and his graduate degree from Johns Hopkins Bloomberg School of Public Health.
Posizioni attive di Justin Fairchild
Società | Posizione | Inizio |
---|---|---|
PORTAGE BIOTECH INC. | Corporate Officer/Principal | 18/08/2022 |
The Parker Institute For Cancer Immunotherapy
![]() The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Justin Fairchild
Johns Hopkins Bloomberg School of Public Health | Graduate Degree |
Colgate University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PORTAGE BIOTECH INC. | Health Technology |
Aziende private | 1 |
---|---|
The Parker Institute For Cancer Immunotherapy
![]() The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Commercial Services |
- Borsa valori
- Insiders
- Justin Fairchild